相关实验视频
Updated: Sep 14, 2025

08:53
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
2.9K
作为癌症治疗目标的RNA剪接
Alexander M Lewis1, Kenyon Weis1, Omar Abdel-Wahab1
1Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA;
Annual review of pharmacology and toxicology
|July 22, 2025
概括
RNA拼接,即信使RNA (mRNA) 成熟的过程,在癌症中经常受到干扰. 针对RNA拼接的治疗策略正在成为有前途的癌症治疗方法.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- RNA拼接是产生成熟的信使RNA (mRNA) 的关键核过程.
- RNA拼接的失调是癌症的常见标志,由遗传,表观遗传和机械改变驱动.
- 改变的拼接有助于癌症的发展和进展.
研究的目的:
- 审查当前的治疗策略,药理学调节癌症中的RNA拼接.
- 讨论针对拼接机械或mRNA转录的小分子和寡核酸.
- 介绍癌症患者的剪接调节剂的早期临床发现.
主要方法:
- 对癌症中RNA拼接调制的现有文献的综述.
- 分析治疗方式,包括小分子和寡核酸.
- 检查用于拼接向治疗的早期临床试验数据.
主要成果:
- 有多种方法可用于药理上准RNA剪接.
- 小分子和寡核酸在调节拼接过程方面表现出潜力.
- 早期的临床试验表明了这些新疗法的可行性和潜在疗效.
结论:
- RNA拼接在瘤学中是一个重要的和可行的治疗目标.
- 向RNA拼接为新型癌症治疗提供了一个有希望的途径.
- 需要进一步的研究和临床评估,才能充分发挥基于拼接的癌症治疗的潜力.
更多相关视频
相关概念视频
RNA Splicing
57.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.1K
Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Pre-mRNA Processing: RNA Splicing
5.4K
5.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Nonsense-mediated mRNA Decay
10.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.8K

